Literature DB >> 11719226

Phenotypic switching of antibiotic resistance circumvents permanent costs in Staphylococcus aureus.

R C Massey1, A Buckling, S J Peacock.   

Abstract

Bacterial antibiotic resistance is often associated with a fitness cost in the absence of the antibiotic [1,2]. We have examined a resistance mechanism in Staphylococcus aureus that negates these costs. Exposure to gentamicin both in vitro and in vivo has been reported to result in the emergence of a gentamicin-resistant small colony variant (SCV)[3-8]. We show that the emergence of SCVs following exposure to gentamicin results from a rapid switch and that bacteria exposed to cycles of gentamicin followed by antibiotic-free medium repeatedly switched between a resistant SCV and a sensitive parental phenotype (revertants). The fitness of revertants relative to S. aureus with stable gentamicin resistance was greater in drug-free media, which suggests that S. aureus has evolved an inducible and reversible resistance mechanism that circumvents a permanent cost to fitness.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11719226     DOI: 10.1016/s0960-9822(01)00507-3

Source DB:  PubMed          Journal:  Curr Biol        ISSN: 0960-9822            Impact factor:   10.834


  44 in total

1.  Thymidine auxotrophic Staphylococcus aureus small-colony variant endocarditis and left ventricular assist device infection.

Authors:  Awele Maduka-Ezeh; Maria Teresa Seville; Shimon Kusne; Holenarasipur R Vikram; Janis E Blair; Kerryl Greenwood-Quaintance; Francisco Arabia; Robin Patel
Journal:  J Clin Microbiol       Date:  2012-01-11       Impact factor: 5.948

2.  Coordinated phenotype switching with large-scale chromosome flip-flop inversion observed in bacteria.

Authors:  Longzhu Cui; Hui-min Neoh; Akira Iwamoto; Keiichi Hiramatsu
Journal:  Proc Natl Acad Sci U S A       Date:  2012-05-29       Impact factor: 11.205

3.  Reverse evolution and evolutionary memory.

Authors:  Michael M Desai
Journal:  Nat Genet       Date:  2009-02       Impact factor: 38.330

4.  Tomatidine inhibits replication of Staphylococcus aureus small-colony variants in cystic fibrosis airway epithelial cells.

Authors:  Gabriel Mitchell; Mariza Gattuso; Gilles Grondin; Éric Marsault; Kamal Bouarab; François Malouin
Journal:  Antimicrob Agents Chemother       Date:  2011-02-28       Impact factor: 5.191

5.  Triclosan-induced aminoglycoside-tolerant Listeria monocytogenes isolates can appear as small-colony variants.

Authors:  Vicky G Kastbjerg; Line Hein-Kristensen; Lone Gram
Journal:  Antimicrob Agents Chemother       Date:  2014-03-17       Impact factor: 5.191

6.  Comparison of antibiotic resistance, virulence gene profiles, and pathogenicity of methicillin-resistant and methicillin-susceptible Staphylococcus aureus using a Caenorhabditis elegans infection model.

Authors:  Terissa Thompson; Paul D Brown
Journal:  Pathog Glob Health       Date:  2014-10-16       Impact factor: 2.894

Review 7.  Recombination, reservoirs, and the modular spike: mechanisms of coronavirus cross-species transmission.

Authors:  Rachel L Graham; Ralph S Baric
Journal:  J Virol       Date:  2009-11-11       Impact factor: 5.103

8.  Staphylococcus aureus sigma B-dependent emergence of small-colony variants and biofilm production following exposure to Pseudomonas aeruginosa 4-hydroxy-2-heptylquinoline-N-oxide.

Authors:  Gabriel Mitchell; David Lalonde Séguin; Ann-Elise Asselin; Eric Déziel; André M Cantin; Eric H Frost; Sophie Michaud; François Malouin
Journal:  BMC Microbiol       Date:  2010-01-30       Impact factor: 3.605

9.  Functional organisation of Escherichia coli transcriptional regulatory network.

Authors:  Agustino Martínez-Antonio; Sarath Chandra Janga; Denis Thieffry
Journal:  J Mol Biol       Date:  2008-05-29       Impact factor: 5.469

10.  A microscope automated fluidic system to study bacterial processes in real time.

Authors:  Adrien Ducret; Etienne Maisonneuve; Philippe Notareschi; Alain Grossi; Tâm Mignot; Sam Dukan
Journal:  PLoS One       Date:  2009-09-30       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.